109 results
Page 4 of 6
6-K
EX-99.1
lx61a6 58xe
26 Jan 22
Immunocore announces FDA approval of KIMMTRAK® (tebentafusp-tebn) for the treatment of unresectable or metastatic uveal melanoma
4:29pm
6-K
EX-99.1
5dy 45yes41n43
10 Nov 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:01am
6-K
EX-99.1
75xg2a9zc k9yfj3r
24 Aug 21
Current report (foreign)
4:33pm
S-8
EX-99.7
98dpr89lc 03std
12 Apr 21
Registration of securities for employees
4:02pm
S-8
EX-99.6
z5v36 zyy2n
12 Apr 21
Registration of securities for employees
4:02pm
S-8
EX-99.8
wx9fv9hsjzzt 0eo1fk3
12 Apr 21
Registration of securities for employees
4:02pm
20-F
EX-2.4
6b0e7e pw
25 Mar 21
Annual report (foreign)
7:01am
20-F
EX-1.1
wfp5xp
25 Mar 21
Annual report (foreign)
7:01am
20-F
EX-2.2
ol37crbm
25 Mar 21
Annual report (foreign)
7:01am
20-F
EX-4.20
l61rihsvd
25 Mar 21
Annual report (foreign)
7:01am
20-F
gzanlm
25 Mar 21
Annual report (foreign)
7:01am
424B4
4y1motj3 r0fwhb9f7
8 Feb 21
Prospectus supplement with pricing info
8:36am
F-1/A
EX-1.1
thlr52
3 Feb 21
Registration statement (foreign) (amended)
5:22pm
F-1/A
0rotzhht8id ya3c6
3 Feb 21
Registration statement (foreign) (amended)
5:22pm
F-1/A
EX-4.3
0h2le43pim5
3 Feb 21
Registration statement (foreign) (amended)
5:22pm
F-6/A
EX-99
w6k3nl
2 Feb 21
Registration for ADRs (foreign) (amended)
4:32pm
F-1/A
EX-3.1
gvey8kywgy stmb03s
1 Feb 21
Registration statement (foreign) (amended)
6:21am
F-1/A
EX-4.1
bc21sx3k2zx39pgqu8n
1 Feb 21
Registration statement (foreign) (amended)
6:21am
F-1/A
EX-1.1
nd0nnh6x5
1 Feb 21
Registration statement (foreign) (amended)
6:21am
F-1/A
EX-10.3
4xfhg0xpwstvl31u7r
1 Feb 21
Registration statement (foreign) (amended)
6:21am